抗体

SLPI / Antileukoproteinase Antibody LS-C10072

LS-C10072

多克隆

domestic goat

未共轭

免疫印迹, 酶联免疫吸附测定, 中和反应

LS-C10072

人类

山羊

SLPI / Antileukoproteinase Antibody LS-C10072

Recognizes human SLPI in direct ELISA and Western Blot. ~20% cross-reactivity with mSLPI (ELISA). Antibody neutralizes SLPI biological activity.

多克隆

未共轭

PBS, pH值7.2, 40% 甘油

重组蛋白

Purified, E. coli-derived, recombinant human secretory leukocyte protease inhibitor (SLPI).

Immunoaffinity purified

Short term: 4°C; Long term: Add glycerol (40-50%) -20°C.

IgG

SLPI / Antileukoproteinase

SLPI

人类

ELISA (0.5 - 1 µg/ml), Neut, WB (0.1 - 0.2 µg/ml)

Antileukoproteinase antibody LS-C10072 is an unconjugated goat polyclonal antibody to human Antileukoproteinase (SLPI). Validated for ELISA, Neut and WB.

Suitable for use in Neutralization, Direct ELISA, Western Blot. Neutralization: ~20 ng of antibody will neutralize 50% of the activity due to 1 ng of rhSLPI. Inhibits trypsin-catalyzed hydrolysis of tosyl-Gly-Pro-Lys-4-nitroanilide acetate. Recombinant human SLPI will inhibit trypsin activity at a 1:1 molar ratio of rhSLPI to active trypsin. Direct ELISA: 0.5-1.0 ug/ml. The detection limit for rhSLPI is approximately 0.03 ng/well. Western Blot: 0.1-0.2 ug/ml with the appropriate secondary reagents to detect human SLPI. The detection limit for rhSLPI is ~1 ng/lane under non-reducing and reducing conditions.

SLPI, ALK1, ALP, Antileukoprotease, BLPI, HUSI, Mucus proteinase inhibitor, HUSI-I, SLP1, Antileukoproteinase, Seminal proteinase inhibitor, WFDC4, HUSI-1, Protease inhibitor WAP4, WAP4

Worldwide